These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9143643)

  • 21. Pretreatment illegal activities of a nationwide sample of adolescent substance abuse clients.
    Kinlock TW; Gordon MS; Battjes RJ
    J Psychoactive Drugs; 2004 Mar; 36(1):5-12. PubMed ID: 15152705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the substance abuse and crime prevention act: treatment clients and program types during the first year of implementation.
    Evans E; Longshore D
    J Psychoactive Drugs; 2004 May; Suppl 2():165-74. PubMed ID: 15279129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical connection: drugs and crime.
    Leukefeld CG
    Int J Addict; 1985; 20(6-7):1049-64. PubMed ID: 3908335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revising the paradigm for jail diversion for people with mental and substance use disorders: Intercept 0.
    Abreu D; Parker TW; Noether CD; Steadman HJ; Case B
    Behav Sci Law; 2017 Sep; 35(5-6):380-395. PubMed ID: 29034504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compulsory drug treatment in Canada: historical origins and recent developments.
    Fischer B; Roberts JV; Kirst M
    Eur Addict Res; 2002 Apr; 8(2):61-8. PubMed ID: 11979008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrating substance abuse treatment and criminal justice supervision.
    Marlowe DB
    Sci Pract Perspect; 2003 Aug; 2(1):4-14. PubMed ID: 18552716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When you assume...the reality of implementing a legally mandated substance abuse treatment program.
    Wiley D; Beattie M; Nguyen H; Puckett K; Banerjee K; Poon W
    J Psychoactive Drugs; 2004 May; Suppl 2():175-80. PubMed ID: 15279130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors of program failure in a juvenile drug court program.
    Konecky B; Cellucci T; Mochrie K
    Addict Behav; 2016 Aug; 59():80-3. PubMed ID: 27077963
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug treatment courts and the disease paradigm.
    Nolan JL
    Subst Use Misuse; 2002; 37(12-13):1723-50. PubMed ID: 12487240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rehab instead of prison: drug courts provide opportunities for nurse practitioners.
    Naegle MA; Richardson H; Morton K
    Am J Nurs; 2004 Jun; 104(6):58-61. PubMed ID: 15187616
    [No Abstract]   [Full Text] [Related]  

  • 31. Factors associated with completion of a drug treatment court diversion program.
    Butzin CA; Saum CA; Scarpitti FR
    Subst Use Misuse; 2002; 37(12-13):1615-33. PubMed ID: 12487236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MAPIT: development of a web-based intervention targeting substance abuse treatment in the criminal justice system.
    Walters ST; Ondersma SJ; Ingersoll KS; Rodriguez M; Lerch J; Rossheim ME; Taxman FS
    J Subst Abuse Treat; 2014 Jan; 46(1):60-5. PubMed ID: 23954392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gender differences in drug treatment careers among clients in the national Drug Abuse Treatment Outcome Study.
    Grella CE; Joshi V
    Am J Drug Alcohol Abuse; 1999 Aug; 25(3):385-406. PubMed ID: 10473004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dope on drug sentencing: new approaches simplify sentencing, get more drug abusers treatment and save states money.
    Lawrence A
    State Legis; 2011 Dec; 37(10):23-5. PubMed ID: 22187757
    [No Abstract]   [Full Text] [Related]  

  • 35. Adapting a substance abuse court diversion model for felony offenders with co-occurring disorders: initial implementation.
    Broner N; Nguyen H; Swern A; Goldfinger S
    Psychiatr Q; 2003; 74(4):361-85. PubMed ID: 14686460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Intervention by NGO of drug addicts who are in the criminal justice system in Japan].
    Oda M
    Masui; 2011 Nov; 60 Suppl():S16-24. PubMed ID: 22458019
    [No Abstract]   [Full Text] [Related]  

  • 37. Trajectories of resilience over 25 years of individuals who as adolescents consulted for substance misuse and a matched comparison group.
    Larm P; Hodgins S; Tengström A; Larsson A
    Addiction; 2010 Jul; 105(7):1216-25. PubMed ID: 20331546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction effects of treatment setting and client characteristics on retention and completion.
    Klein C; di Menza S; Arfken C; Schuster CR
    J Psychoactive Drugs; 2002; 34(1):39-50. PubMed ID: 12003112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intellectual abilities and motivation toward substance abuse treatment in drug-involved offenders: a pilot study in the Belgian criminal justice system.
    Vandevelde S; Broekaert E; Schuyten G; Van Hove G
    Int J Offender Ther Comp Criminol; 2005 Jun; 49(3):277-97. PubMed ID: 15851508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addiction, intoxication, criminal law and criminal justice: an introduction.
    Albrecht H
    Eur Addict Res; 1998 Sep; 4(3):85-8. PubMed ID: 9742269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.